Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension

Condition:   Hypertension Interventions:   Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: Placebo Sponsor:   George Medicines PTY Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials